This is a preview of subscription content, log in via an institution to check access.
Notes
Of the University Hospital of Southampton, and the Royal College of Ophthalmologists, respectively.
Reference
Lotery A, et al. What is stopping the NHS from using bevacizumab for macular degeneration and other retinal disorders? BMJ : 19 Nov 2014. Available from: URL: http://dx.doi.org/10.1136/bmj.g6887
Rights and permissions
About this article
Cite this article
Bevacizumab for AMD could save UK's NHS £ millions. PharmacoEcon Outcomes News 717, 3 (2014). https://doi.org/10.1007/s40274-014-1728-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-014-1728-8